ESSA Pharma Inc.

EPIX

Pharmaceutical Preparations·VANCOUVER

CEO

Parkinson David Ross

CFO

Wood David S.

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q2 2025	6/30/25	8/13/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-Q	Q4 2024	12/31/24	2/11/25	→
10-K	FY 2024	9/30/24	12/17/24	→
10-Q	Q2 2024	6/30/24	8/5/24	→
10-Q	Q1 2024	3/31/24	5/14/24	→
↓

Earnings Releases (8-K)

15 shown

Filed	Period
5/8/25	Q3 FY2025	→
2/11/25	Q2 FY2025	→
12/17/24	Q1 FY2025	→
8/5/24	Q4 FY2024	→
5/14/24	Q3 FY2024	→
2/13/24	Q2 FY2024	→
↓

News (8-K)

37 shown

Filed	Type	Description
10/9/25	Delisting	Completion of Acquisition or Disposition of Assets	→
10/6/25	Vote	Submission of Matters to a Vote of Security Holders	→
10/3/25	Other	Other Events	→
9/30/25	Other	Other Events	→
9/24/25	Agreement	Entry into a Material Definitive Agreement	→
9/10/25	Other	Other Events	→
↓

Prospectuses & Registrations

32 shown

Filed	Form	Description
10/15/25	S-8 POS	S-8 POS	→
10/15/25	S-8 POS	S-8 POS	→
10/15/25	S-8 POS	S-8 POS	→
10/15/25	S-8 POS	S-8 POS	→
10/15/25	S-8 POS	S-8 POS	→
4/5/24	S-8	S-8	→
↓

Filing History(513 filings)

TypeDateAccessionPeriodSize

EFFECT

Nov 14, 2025

9999999995-25-003286

—

1.8 KB

SCHEDULE 13G/A

Nov 14, 2025

0001214659-25-016689

—

14.4 KB

SCHEDULE 13G/A

Nov 14, 2025

0001214659-25-016682

—

14.4 KB

15-12G

Oct 28, 2025

0001104659-25-10292215-12G

—

10.2 KB

Oct 15, 2025

0001104659-25-099659OWNERSHIP DOCUMENT

Oct 9, 2025

5.4 KB

Oct 15, 2025

0001104659-25-099657OWNERSHIP DOCUMENT

Oct 9, 2025

5.3 KB

Oct 15, 2025

0001104659-25-099655OWNERSHIP DOCUMENT

Oct 9, 2025

5.3 KB

Oct 15, 2025

0001104659-25-099652OWNERSHIP DOCUMENT

Oct 9, 2025

5.3 KB

Oct 15, 2025

0001104659-25-099650OWNERSHIP DOCUMENT

Oct 9, 2025

5.3 KB

Oct 15, 2025

0001104659-25-099647OWNERSHIP DOCUMENT

Oct 9, 2025

5.3 KB

Oct 15, 2025

0001104659-25-099644OWNERSHIP DOCUMENT

Oct 9, 2025

5.3 KB

POS AM

Oct 15, 2025

0001104659-25-099619POS AM

—

23.3 KB

S-8 POS

Oct 15, 2025

0001104659-25-099618S-8 POS

—

27.1 KB

S-8 POS

Oct 15, 2025

0001104659-25-099617S-8 POS

—

27.1 KB

S-8 POS

Oct 15, 2025

0001104659-25-099616S-8 POS

—

27.1 KB

S-8 POS

Oct 15, 2025

0001104659-25-099615S-8 POS

—

27.1 KB

S-8 POS

Oct 15, 2025

0001104659-25-099613S-8 POS

—

27.1 KB

Oct 14, 2025

0000921895-25-002742OWNERSHIP DOCUMENT

Oct 9, 2025

27.1 KB

SCHEDULE 13D/A

Oct 14, 2025

0000921895-25-002741

—

17.8 KB

25-NSE

Oct 9, 2025

0001354457-25-001005

—

3.0 KB

8-K

Oct 9, 2025

0001104659-25-098078FORM 8-K

Oct 9, 2025

219.5 KB

SCHEDULE 13G/A

Oct 7, 2025

0000895421-25-000531

—

12.0 KB

8-K

Oct 6, 2025

0001104659-25-097168FORM 8-K

Oct 3, 2025

244.7 KB

DEFA14A

Oct 3, 2025

0001104659-25-096311DEFA14A

—

37.9 KB

8-K

Oct 3, 2025

0001104659-25-096306FORM 8-K

Sep 30, 2025

204.6 KB

25 filings shown

ESSA Pharma Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(513 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
10/15/25	4	OWNERSHIP DOCUMENT	→
10/15/25	4	OWNERSHIP DOCUMENT	→
10/15/25	4	OWNERSHIP DOCUMENT	→
10/15/25	4	OWNERSHIP DOCUMENT	→
10/15/25	4	OWNERSHIP DOCUMENT	→
10/15/25	4	OWNERSHIP DOCUMENT	→
↓

Filed	Form	Description
11/14/25	EFFECT	EFFECT	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
10/28/25	15-12G	15-12G	→
10/15/25	POS AM	POS AM	→
10/14/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
↓